Global Therapeutic and Preventive Vaccines Market Size, Share of & Trends Analysis Report by Type, by End-User, and Forecast 2019-2025. The global market for therapeutic and preventive vaccines is expected to grow at an impressive rate of 9.3% during the forecast period.
The global market for therapeutic and preventive vaccines is expected to grow at an impressive growth rate of 9.3% during the forecast period. The increase in funding for DNA vaccination activities is primarily driving the therapeutic and preventive vaccine market in North America.
For example, the Bill and Melinda Gates Foundation donated 1.4 million US dollars to the Wistar Institute (Philadelphia) in January 2018 – Granted dollars for the development of a synthetic DNA-based vaccine against malaria. The Wistar Institute will collaborate with Inovia Pharmaceuticals, Inc.
With this research grant from the Gates Foundation, the Wistar Institute and its partners are planning to develop a vaccine against Plasmodium falciparum. The synthetic vaccine was developed to instruct the body to produce malaria-specific antigens.
As a result, the immune system is activated to produce a highly effective immune response.
According to the WHO, the governments of the epidemic countries had 800 in 2016 Million US dollars, which is 31% of the total funding. The US was the largest contributor to international funding for a malaria control program in 2016.
The country offered $ 1 billion, representing 38% of total malaria funding, followed by other major donors such as the UK, France, Germany and Japan .
According to the Centers for Disease Control and Prevention (CDC), nearly 1,700 cases of malaria are reported in the US each year. Such a higher prevalence of malaria is the main reason North America is encouraged to help companies conduct research that will enable them to fight malaria. This expands the global therapeutic and preventive vaccines market.
Strict regulations in China that mandate vaccinations expand the market size of the global therapeutic and preventive vaccines market
In China, it is mandatory under Chinese law that the Child to inject the vaccine against hepatitis B (HBV) and tuberculosis TB (BCG) immediately after birth. This escalates the global growth of the therapeutic and preventive vaccine market in China.
China began its Expanded Immunization Program (EPI) in 1992. It includes a mandatory 11 vaccine schedule to be given to children ages 0 to 6 years old.
The mandatory vaccines in China are hepatitis B (HBV), Japanese encephalitis (JE) and hepatitis A (HAV) . Along with this, the recommended vaccines are chickenpox, rotavirus and rabies.
In 2014, the WHO renewed the qualification of the Chinese regulatory authority’s (CNRA) vaccine supervisors. The Chinese Food and Drug Administration (CFDA) in the context of the CNRA questions on the manufacture of vaccines had granted a license to 34 companies that meet the necessary requirements for international manufacturing practice.
Orion Market Research (OMR) is a market research company and consulting firm known for its clear and concise reports. The company has an experienced team of analysts and consultants.
Donnez votre avis et abonnez-vous pour plus d’infos
Vidéo du jour: